Interleukin-6 levels in children developing SARS-CoV-2 infection
Gita Vita Soraya, Zulvikar Syambani Ulhaq
Abstract
Since the declaration of the coronavirus disease 2019 (COVID-19) pandemic status, the total number of cases developing severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has reached 1,696,588 worldwide, with a mortality rate of 6.24%.1 Interestingly, reports have shown that, compared to adults, the pediatric populations have lower infection rates, less severe clinical presentation with lower likelihood of progression, and more favorable prognosis.2 However, the mechanism behind this phenomenon remains elusive.
Topics & Concepts
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakMedicineBiologyOutbreakInternal medicineInfectious disease (medical specialty)DiseaseCOVID-19 Impact on ReproductionCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research